Genome Hazard Box Office Collection, Budget & Verdict
Financial Breakdown
| Category | Amount (Approx) |
|---|---|
| Official Budget | TBA |
| Worldwide Gross | TBA |
| IMDb Rating | / 10 |
Detailed Financial Report
Genome Hazard, released in 2014, entered the cinematic marketplace with the goal of capturing global audiences. Production insiders estimate the budget to be around an undisclosed amount. This figure typically includes principal photography, talent fees, and post-production costs, but often excludes marketing and distribution expenses which can add another 30-50% to the total investment.
Collection Trajectory
The box office journey for Genome Hazard has culminated in a worldwide gross of approximately TBA. The figures indicate a competitive response, with the film navigating a complex theatrical landscape.
Profitability & Verdict
In the modern film economy, theatrical revenue is just one slice of the pie. However, it remains the primary indicator of a film's "Hit" or "Flop" status. Based on the reported numbers and audience reception (6.8/10), Genome Hazard is effectively categorized as a Commercial Success.
Comparables
When compared to other Thriller releases of 2014, Genome Hazard stands as a testament to the enduring appeal of the genre. Its performance will likely influence studio decisions for future projects in this category.
Frequently Asked Questions
How much did Genome Hazard earn at the box office?
Genome Hazard has grossed approximately TBA worldwide as of our latest data updating this 2014 report.
What was the production budget for Genome Hazard?
The reported production cost for Genome Hazard was roughly TBA, excluding marketing and distribution.
Is Genome Hazard a box office hit or flop?
Based on its worldwide collection of TBA against a budget of TBA, the film's rating is 6.8/10, indicating it was a commercial success.